Real-World Experience With VMAT2 Inhibitors

Conclusions The VMAT2 inhibitors are effective and safe in a range of hyperkinetic movement disorders but are not readily accessible by patients in the United States for indications not approved by the Food and Drug Administration.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research